Clinical Effect of Stellate Ganglion Block on Gastroesophageal Reflux Disease
NCT06215742 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL
Last updated 2024-03-05
Summary
The goal of this clinical trial is to explore Clinical Effect of Stellate Ganglion Block on Gastroesophageal Reflux Disease. The main question it aims to answer is:
• Can stellate ganglion block improve gastroesophageal reflux symptoms better on the basis of rehabilitation training? Participants will be randomly allocated into the control group or the experimental group, all under rehabilitation treatment, the experimental group will be given Stellate Ganglion Block once a day additionally. The study lasts 20 days for each participant. Researchers will compare the Gastroesophageal Reflux Disease Questionnaire, Pressure pain threshold, Self-Evaluation Questionnaire for Gastroesophageal Reflux Disease, to see if the Stellate Ganglion Block can help improve the symptom.
Conditions
- Gastroesophageal Reflux Disease
Interventions
- BEHAVIORAL
-
Rehabilitation therapy
Rehabilitation therapy includes 1. Diet management: Avoiding consumption of irritant foods and beverages, such as spicy foods, caffeine, alcohol, and acidic foods. Controlling portion sizes and meal timing, and adopting smaller, more frequent meals. 2. Lifestyle adjustments: Avoiding lying down or bending immediately after meals, maintaining a sitting or upright position for at least 2 hours. Adjusting sleeping positions by elevating the head of the bed to reduce nighttime acid reflux. Avoiding excessive exertion and managing stress levels. 3. Rehabilitation training: Strengthening the control of esophageal and gastric muscles through rehabilitation exercises to improve the function of the gastroesophageal sphincter and prevent gastric fluid reflux.
- PROCEDURE
-
Stellate ganglion block
Based on the invention above, the patients in the observation group were provided with Stellate ganglion block, using 1.5ml of 2% Lidocaine hydrochloride (1ml: 0.5mg) and 500ug of Vitamin B12 (1ml: 0.5g). The percutaneous approach via the paratracheal route was used for Stellate ganglion block. The operator stood on the side of the block, instructed the patient to lie supine with a thin pillow placed below the shoulders, and tilted the head 45° towards the blocked side, fully exposing the neck. Then, routine disinfection of the neck skin was performed. The puncture site was located 2.5 cm above the sternoclavicular joint and 1.5 cm lateral to the midline of the neck.
Sponsors & Collaborators
-
Zeng Changhao
lead OTHER
Principal Investigators
-
Nieto Luis, Master · Site Coordinator of United Medical Group located in Miami
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-01-30
- Primary Completion
- 2024-04-30
- Completion
- 2024-05-15
Countries
- China
Study Locations
More Related Trials
-
Evaluation of the Efficiency of Radiofrequency in the Treatment of Gastroesophageal Reflux Disease
NCT00200642 ·Status: COMPLETED ·Phase: NA
-
the Efficency and Safety of Stretta in GERD
NCT03574831 ·Status: UNKNOWN
-
Effect of Manual Diaphragmatic Activation on Diaphragm Function in Patients With Gastroesophageal Reflux Disease
NCT06268548 ·Status: RECRUITING ·Phase: NA
-
Stretta Versus Conservative Treatment
NCT05781347 ·Status: RECRUITING ·Phase: NA
-
Treatment Of Gastroesophageal Reflux Disease By Endoscopic Fundoplication, A Placebo-Controlled Study
NCT00235677 ·Status: COMPLETED ·Phase: PHASE3
-
Mirabegron in Achalasia: A Clinical and Manometric Proof of Concept Pilot Study
NCT03411252 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
Impact of Glossopharyngeal Nerve Block on Swallowing Difficulties Caused by Gastroesophageal Reflux Disease
NCT06328205 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Understanding the Pathophysiology and Effects of Diaphragmatic Breathing in Upright Gastroesophageal Reflux
NCT02972047 ·Status: COMPLETED ·Phase: NA
-
Management of Reflux After Sleeve Using Stretta
NCT02637713 ·Status: TERMINATED ·Phase: NA
-
Medical and Surgical Treatment of Esophageal Reflux
NCT00061724 ·Status: COMPLETED
-
Outcomes After Medical and Surgical Treatment of Gastroesophageal Reflux Disease
NCT00260572 ·Status: ACTIVE_NOT_RECRUITING
-
Gastroesophageal Reflux Disease Diagnostic Trial
NCT06504134 ·Status: NOT_YET_RECRUITING
-
Diaphragmatic Myofascial Release in Gastroesophageal Reflux Disease
NCT03299985 ·Status: COMPLETED ·Phase: NA
-
STRETTA ,Radio Frequency Ablation (RFA) v/s Sham Therapy for the Treatment of Refractory GERD
NCT02935881 ·Status: UNKNOWN ·Phase: PHASE3
-
[Impedance Measurement for Non-Erosive Reflux Disease
NCT02997527 ·Status: WITHDRAWN ·Phase: NA
-
Real-life Study of Changes of Gastroesophageal Reflux Disease Manifestations Due to Behavioural and Diet Adherence
NCT04255693 ·Status: RECRUITING ·Phase: NA
-
Gastroesophageal Reflux Disease Prospective Registry
NCT02479438 ·Status: TERMINATED
-
Sensorimotor Dysfunction in Achalasia
NCT02434991 ·Status: WITHDRAWN ·Phase: NA
-
Impact of Weight Loss on Gastroesophageal Reflux Disease in Overweight and Obese Subjects: a Prospective Study
NCT01574573 ·Status: TERMINATED ·Phase: NA
-
Breathing Exercises in Patients With Gastroesophageal Reflux
NCT06812650 ·Status: COMPLETED ·Phase: NA
-
An Investigation of the EndoStim® Lower Esophageal Sphincter (LES) Stimulation System for the Treatment of Reflux
NCT02749071 ·Status: TERMINATED ·Phase: NA
-
Quality of Life in Barrett's Esophagus and Gastro-Esophageal Reflux Disease
NCT01572974 ·Status: TERMINATED
-
Stretta Treatment in GERD After SG
NCT05094895 ·Status: UNKNOWN ·Phase: NA
-
Efficacy Of Hiatal Closure For GERD
NCT06280664 ·Status: RECRUITING
-
Manual Therapy and Gastroesophageal Reflux Disease in Patients With Hiatal Hernia
NCT05283447 ·Status: COMPLETED ·Phase: NA